{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:09:40Z","timestamp":1778598580048,"version":"3.51.4"},"reference-count":6,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"DOI":"10.1515\/cclm-2025-0382","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T01:56:14Z","timestamp":1744854974000},"page":"e172-e174","source":"Crossref","is-referenced-by-count":2,"title":["The first case of Teclistamab interference with serum electrophoresis and immunofixation"],"prefix":"10.1515","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1687-651X","authenticated-orcid":false,"given":"Kamran","family":"Kadkhoda","sequence":"first","affiliation":[{"name":"Immunopathology Laboratory, Robert J.\u00a0Tomsich Pathology and Laboratory Medicine Department , 202569 Diagnostics Institute, Cleveland Clinic , Cleveland , OH , USA"},{"name":"202569 Department of Pathology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University , Cleveland , OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Faiman","sequence":"additional","affiliation":[{"name":"202569 Department of Hematology and Medical Oncology, Cleveland Clinic , Cleveland , OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Valent","sequence":"additional","affiliation":[{"name":"202569 Department of Hematology and Medical Oncology, Cleveland Clinic , Cleveland , OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Albahra","sequence":"additional","affiliation":[{"name":"Center for Artificial Intelligence & Data Science, Robert J.\u00a0Tomsich Pathology and Laboratory Medicine Department , 2569 Diagnostics Institute, Cleveland Clinic , Cleveland , OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Boyert","sequence":"additional","affiliation":[{"name":"Immunopathology Laboratory, Robert J.\u00a0Tomsich Pathology and Laboratory Medicine Department , 202569 Diagnostics Institute, Cleveland Clinic , Cleveland , OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2026051214225328885_j_cclm-2025-0382_ref_001","doi-asserted-by":"crossref","unstructured":"Lokhorst, HM, Plesner, T, Laubach, JP, Nahi, H, Gimsing, P, Hansson, M, et al.. Targeting CD38 with daratumumab monotherapy in multiple myeloma. N\u00a0Engl J Med 2015;373:1207\u201319. https:\/\/doi.org\/10.1056\/nejmoa1506348.","DOI":"10.1056\/NEJMoa1506348"},{"key":"2026051214225328885_j_cclm-2025-0382_ref_002","doi-asserted-by":"crossref","unstructured":"Tang, F, Malek, E, Math, S, Schmotzer, CL, Beck, RC. Interference of therapeutic monoclonal antibodies with routine serum protein electrophoresis and immunofixation in patients with myeloma: frequency and duration of detection of daratumumab and elotuzumab. Am J Clin Pathol 2018;150:121\u20139. https:\/\/doi.org\/10.1093\/ajcp\/aqy037.","DOI":"10.1093\/ajcp\/aqy037"},{"key":"2026051214225328885_j_cclm-2025-0382_ref_003","doi-asserted-by":"crossref","unstructured":"Rajkumar, SV, Dimopoulos, MA, Palumbo, A, Blade, J, Merlini, G, Mateos, MV, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538\u201348. https:\/\/doi.org\/10.1016\/s1470-2045(14)70442-5.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"2026051214225328885_j_cclm-2025-0382_ref_004","doi-asserted-by":"crossref","unstructured":"Bonilla-Valent\u00edn, FJ, Cerra, J, C\u00e1ceres-Perkins, W, Alsina, M. Case report of IgM multiple myeloma: diagnosing a rare hematologic entity. Cancer Control 2018;25:1073274817744448. https:\/\/doi.org\/10.1177\/1073274817744448.","DOI":"10.1177\/1073274817744448"},{"key":"2026051214225328885_j_cclm-2025-0382_ref_005","doi-asserted-by":"crossref","unstructured":"Guo, Y, Quijano Card\u00e9, NA, Kang, L, Verona, R, Banerjee, A, Kobos, R, et al.. Teclistamab: mechanism of action, clinical, and translational science. Clin Transl Sci 2024;17:e13717. https:\/\/doi.org\/10.1111\/cts.13717.","DOI":"10.1111\/cts.13717"},{"key":"2026051214225328885_j_cclm-2025-0382_ref_006","doi-asserted-by":"crossref","unstructured":"Sheldon, J, Wheeler, RD, Powles, R. Electrophoretic patterns post daratumumab. Ann Clin Biochem 2018;55:299\u2013301. https:\/\/doi.org\/10.1177\/0004563217710489.","DOI":"10.1177\/0004563217710489"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0382\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:31:57Z","timestamp":1778596317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0382\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":6,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,6,26]]}},"alternative-id":["10.1515\/cclm-2025-0382"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-0382","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}